GLP-1 receptor agonists for weight reduction in people living with obesity
(2015) Organogenesis : Identified GHK-Cu's influence on 4,000+ human genes, demonstrating its ability to reset aging gene expression patterns

Jessica Zering Year in Review: New Antibiotics and Antibiotic Use Guidance for UTI, CAP, and Beyond FEATURING Jessica Zering 1,209 views January 9, 2026 3 Nephrology Year in Review 2025 Hyponatremia - Top Tips for 2026 FEATURING Mohammed Elhassan 1,077 views February 2, 2026 2 Year in Review 2025 Precision Nephrology in 2026 - Cardio-Kidney Metabolic Disease, GN, and AI Integration FEATURING Louise Moist 237 views January 16, 2026 1 Year in Review 2025 Year in Review 2025: Cardiorenal Metabolic Syndrome and Precision Nephrology - New Era in Kidney Disease Prevention FEATURING Alessia Fornoni 147 views January 16, 2026 Year in Review 2025 Year in Review 2025: MBD Management in Dialysis - Navigating Pharmacy Access, New Binders, and Policy Updates FEATURING Matilde Ladnier 106 views January 16, 2026 Year in Review 2025 Year in Review 2025: CKM Syndrome ManagementGuidelines for Slowing CKD and Cardiovascular Progression FEATURING Susanne B

Wegovy highlights of prescribing information, Food and Drug Administration (2024) Adipex-P highlights of prescribing information, Food and Drug Administration (2012) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) Medications for obesity management: Effectiveness and value, Journal of Managed Care and Specialty Pharmacy (2023) A narrative review of approved and emerging anti-obesity medications, Saudi Pharmaceutical Journal (2023) Label: Wegovy, DailyMed (2024) Label: ADIPEX-P- phentermine hydrochloride tablet, DailyMed (2024) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice